• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基线血清尿酸水平与经皮冠状动脉介入治疗后急性冠状动脉综合征患者的全因死亡率相关。

Baseline Serum Uric Acid Levels Are Associated with All-Cause Mortality in Acute Coronary Syndrome Patients after Percutaneous Coronary Intervention.

机构信息

Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.

Department of Orthodontic, The Affiliated Dental Hospital of Guangxi Medical University, Nanning, Guangxi, China.

出版信息

Dis Markers. 2018 Dec 17;2018:9731374. doi: 10.1155/2018/9731374. eCollection 2018.

DOI:10.1155/2018/9731374
PMID:30647801
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6311730/
Abstract

BACKGROUND

Whether serum uric acid (UA) is associated with all-cause mortality in patients with acute coronary syndrome (ACS) following percutaneous coronary intervention (PCI) remains unclear.

METHODS

We performed a retrospective cohort study of 2296 patients with ACS. Curve-fitting and Cox proportional-hazard regression models with a hazard ratio (HR) and 95% confidence interval (CI) were used.

RESULTS

During a mean follow-up of 246.31 ± 49.16 days, 168 (7.32%) patients died from all causes. Patients were divided into two groups [the high-UA group ( = 566) and the low-UA group ( = 1730)] based on the serum UA threshold value (5.6 mg/dl) identified through curve fitting. Fifty-three (9.36%) patients died in the high-UA group, and 115 (6.65%) patients died in the low-UA group. The difference between groups was statistically significant ( = 0.031). Univariate analysis showed that the risk of all-cause mortality in the high-UA group was significantly greater than that in the low-UA group (HR = 1.45, 95% CI: 1.03 to 2.04). This difference persisted after adjustment for baseline characteristics, medical history, and medication history (HR = 1.42, 95% CI: 1.05 to 1.87).

CONCLUSIONS

Our study demonstrated that elevated serum UA (>5.6 mg/dl) is associated with all-cause mortality in ASC patients after PCI.

摘要

背景

血清尿酸(UA)是否与经皮冠状动脉介入治疗(PCI)后急性冠脉综合征(ACS)患者的全因死亡率相关尚不清楚。

方法

我们对 2296 例 ACS 患者进行了回顾性队列研究。采用曲线拟合和 Cox 比例风险回归模型,计算风险比(HR)和 95%置信区间(CI)。

结果

在平均 246.31±49.16 天的随访期间,168 例(7.32%)患者死于各种原因。根据曲线拟合确定的血清 UA 阈值(5.6mg/dl),将患者分为两组[高 UA 组( = 566)和低 UA 组( = 1730)]。高 UA 组中有 53 例(9.36%)患者死亡,低 UA 组中有 115 例(6.65%)患者死亡。两组之间的差异具有统计学意义( = 0.031)。单因素分析显示,高 UA 组的全因死亡率显著高于低 UA 组(HR=1.45,95%CI:1.032.04)。调整基线特征、病史和用药史后,这种差异仍然存在(HR=1.42,95%CI:1.051.87)。

结论

本研究表明,PCI 后 ASC 患者血清 UA 升高(>5.6mg/dl)与全因死亡率相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91ca/6311730/c8c9d7238f9f/DM2018-9731374.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91ca/6311730/373024088ad2/DM2018-9731374.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91ca/6311730/fcfe75a1d5f1/DM2018-9731374.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91ca/6311730/c8c9d7238f9f/DM2018-9731374.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91ca/6311730/373024088ad2/DM2018-9731374.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91ca/6311730/fcfe75a1d5f1/DM2018-9731374.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91ca/6311730/c8c9d7238f9f/DM2018-9731374.003.jpg

相似文献

1
Baseline Serum Uric Acid Levels Are Associated with All-Cause Mortality in Acute Coronary Syndrome Patients after Percutaneous Coronary Intervention.基线血清尿酸水平与经皮冠状动脉介入治疗后急性冠状动脉综合征患者的全因死亡率相关。
Dis Markers. 2018 Dec 17;2018:9731374. doi: 10.1155/2018/9731374. eCollection 2018.
2
Gender differences in the association between serum uric acid and prognosis in patients with acute coronary syndrome.急性冠脉综合征患者血清尿酸水平与预后之间关联的性别差异
J Cardiol. 2016 Feb;67(2):170-6. doi: 10.1016/j.jjcc.2015.05.009. Epub 2015 Jul 27.
3
Uric acid is associated with long-term adverse cardiovascular outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention.尿酸与行经皮冠状动脉介入治疗的急性冠状动脉综合征患者的长期不良心血管结局相关。
Atherosclerosis. 2018 Mar;270:173-179. doi: 10.1016/j.atherosclerosis.2018.02.003. Epub 2018 Feb 10.
4
Evaluation of the prognostic ability of serum uric acid for elderly acute coronary syndrome patients with diabetes mellitus: a prospective cohort study.评估血尿酸对老年急性冠脉综合征合并糖尿病患者的预后能力:一项前瞻性队列研究。
J Zhejiang Univ Sci B. 2021 Oct 15;22(10):856-865. doi: 10.1631/jzus.B2000637.
5
Impact of hyperuricemia on clinical outcomes after percutaneous coronary intervention for in-stent restenosis.高尿酸血症对经皮冠状动脉介入治疗支架内再狭窄后临床结局的影响。
BMC Cardiovasc Disord. 2018 Jun 11;18(1):114. doi: 10.1186/s12872-018-0840-2.
6
Serum uric acid on admission predicts in-hospital mortality in patients with acute coronary syndrome.急性冠脉综合征患者入院时的血清尿酸可预测住院死亡率。
Int J Cardiol. 2017 Aug 1;240:25-29. doi: 10.1016/j.ijcard.2017.04.027. Epub 2017 Apr 11.
7
The Association Between Serum Uric Acid and Mortality in Patients with Acute Coronary Syndrome After Percutaneous Coronary Intervention.血清尿酸与经皮冠状动脉介入治疗后急性冠状动脉综合征患者死亡率的关系。
Int Heart J. 2022 May 31;63(3):447-453. doi: 10.1536/ihj.21-764. Epub 2022 May 14.
8
Association of variability in uric acid and future clinical outcomes of patient with coronary artery disease undergoing percutaneous coronary intervention.尿酸变异性与经皮冠状动脉介入治疗的冠心病患者未来临床结局的关系。
Atherosclerosis. 2020 Mar;297:40-46. doi: 10.1016/j.atherosclerosis.2020.01.025. Epub 2020 Jan 30.
9
Does the subtype of acute coronary syndrome treated by percutaneous coronary intervention predict long-term clinical outcomes?经皮冠状动脉介入治疗的急性冠状动脉综合征亚型是否预测长期临床结局?
Eur Heart J Qual Care Clin Outcomes. 2018 Oct 1;4(4):318-327. doi: 10.1093/ehjqcco/qcy009.
10
Elevated serum uric acid is an independent predictor for cardiovascular events in patients with severe coronary artery stenosis: subanalysis of the Japanese Coronary Artery Disease (JCAD) Study.血清尿酸升高是严重冠状动脉狭窄患者心血管事件的独立预测因素:日本冠状动脉疾病(JCAD)研究的亚组分析。
Circ J. 2009 May;73(5):885-91. doi: 10.1253/circj.cj-08-0828. Epub 2009 Mar 31.

引用本文的文献

1
Serum uric acid trajectories and the risk of cardiovascular disease: a longitudinal association and pathway analysis.血清尿酸轨迹与心血管疾病风险:纵向关联及路径分析
Endocrine. 2025 Feb;87(2):543-553. doi: 10.1007/s12020-024-04038-1. Epub 2024 Oct 4.
2
Effect of Ticagrelor versus Clopidogrel on All-Cause and Cardiovascular Mortality in Acute Coronary Syndrome Patients with Hyperuricemia.替格瑞洛对比氯吡格雷对伴有高尿酸血症的急性冠状动脉综合征患者全因和心血管死亡率的影响。
Clin Drug Investig. 2024 Mar;44(3):163-174. doi: 10.1007/s40261-024-01342-6. Epub 2024 Feb 7.
3
Impact of serum uric acid levels on the clinical prognosis and severity of coronary artery disease in patients with acute coronary syndrome and hypertension after percutaneous coronary intervention: a prospective cohort study.

本文引用的文献

1
Risk reclassification ability of uric acid for cardiovascular outcomes in essential hypertension.原发性高血压患者中尿酸对心血管结局的风险重新分类能力。
Int J Cardiol. 2017 Sep 15;243:473-478. doi: 10.1016/j.ijcard.2017.05.051. Epub 2017 May 13.
2
Effect of high-dose rosuvastatin loading before percutaneous coronary intervention in Chinese patients with acute coronary syndrome: A systematic review and meta-analysis.大剂量瑞舒伐他汀负荷量在接受经皮冠状动脉介入治疗的中国急性冠脉综合征患者中的作用:一项系统评价和荟萃分析。
PLoS One. 2017 Feb 23;12(2):e0171682. doi: 10.1371/journal.pone.0171682. eCollection 2017.
3
Diabetes as a risk factor for acute coronary syndrome in women compared with men: a meta-analysis, including 10 856 279 individuals and 106 703 acute coronary syndrome events.
血清尿酸水平对经皮冠状动脉介入治疗后合并急性冠脉综合征和高血压的冠心病患者临床预后和严重程度的影响:一项前瞻性队列研究。
BMJ Open. 2022 Jan 12;12(1):e052031. doi: 10.1136/bmjopen-2021-052031.
与男性相比,糖尿病作为女性急性冠状动脉综合征的危险因素:一项荟萃分析,纳入10856279例个体和106703例急性冠状动脉综合征事件。
Diabetes Metab Res Rev. 2017 Jul;33(5). doi: 10.1002/dmrr.2887. Epub 2017 Feb 23.
4
Uric acid metabolism of kidney and intestine in a rat model of chronic kidney disease.慢性肾脏病大鼠模型中肾脏和肠道的尿酸代谢
Nucleosides Nucleotides Nucleic Acids. 2016 Dec;35(10-12):550-558. doi: 10.1080/15257770.2016.1163379.
5
New insights into spotty calcification and plaque rupture in acute coronary syndrome: an optical coherence tomography study.急性冠状动脉综合征中斑点状钙化和斑块破裂的新见解:一项光学相干断层扫描研究
Heart Vessels. 2016 Dec;31(12):1915-1922. doi: 10.1007/s00380-016-0820-3. Epub 2016 Mar 5.
6
Association Between Serum Uric Acid Levels/Hyperuricemia and Hypertension Among 85,286 Japanese Workers.85286名日本工人血清尿酸水平/高尿酸血症与高血压之间的关联
J Clin Hypertens (Greenwich). 2016 Jan;18(1):53-9. doi: 10.1111/jch.12627. Epub 2015 Jul 25.
7
Socioeconomic Status and in-hospital Mortality of Acute Coronary Syndrome: Can Education and Occupation Serve as Preventive Measures?社会经济地位与急性冠状动脉综合征的院内死亡率:教育和职业能否作为预防措施?
Int J Prev Med. 2015 May 4;6:36. doi: 10.4103/2008-7802.156266. eCollection 2015.
8
Serum Uric Acid and Prehypertension Among Adults Free of Cardiovascular Diseases and Diabetes: Baseline of the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil).无心血管疾病和糖尿病的成年人中的血清尿酸与高血压前期:巴西成人健康纵向研究(ELSA-Brasil)的基线情况
Angiology. 2016 Feb;67(2):180-6. doi: 10.1177/0003319715585037. Epub 2015 May 13.
9
Impact of sex on uric acid levels and its relationship with the extent of coronary artery disease: A single-centre study.性别对尿酸水平的影响及其与冠状动脉疾病程度的关系:一项单中心研究。
Atherosclerosis. 2015 Jul;241(1):241-8. doi: 10.1016/j.atherosclerosis.2015.03.030. Epub 2015 Mar 20.
10
Lipoprotein-associated phospholipase A₂ is related to plaque stability and is a potential biomarker for acute coronary syndrome.脂蛋白相关磷脂酶A₂与斑块稳定性相关,是急性冠状动脉综合征的潜在生物标志物。
Yonsei Med J. 2014 Nov;55(6):1507-15. doi: 10.3349/ymj.2014.55.6.1507.